Our Research Trials

We are are committed to driving forward high-quality clinical research that leads to better treatments, earlier diagnoses, and improved outcomes for patients across our communities. Our research trials span a wide range of priority health areas, reflecting both local needs and national ambitions for advancing healthcare.

Our upcoming and ongoing trials will focus on several key conditions, including cancer, obesity, and infectious diseases such as influenza and respiratory syncytial virus (RSV). These areas represent some of the most pressing challenges in modern medicine, and our work aims to contribute to faster innovation and more effective interventions.

Through the CRDC model, we are working to streamline the set-up and delivery of commercial research studies, reducing delays and making it easier for sponsors and research partners to open new trials in the region. This means that patients will have earlier access to cutting-edge treatments and therapies, often long before they become widely available in the NHS.

By increasing research capacity, strengthening partnerships across local hospitals and primary care, and ensuring consistent high standards in trial delivery, the North Midlands CRDC is helping to bring the latest medical advancements directly to the people who need them.